2015 American Transplant Congress Archives

Ideal Versus Total Body Weight Dosing of Rabbit Anti-Thymocyte Globulin Induction Therapy on Patient Outcomes in High Immunological Risk Kidney Transplant

M. Vacha, J. Gommer, A. Rege, S. Sanoff, D. Sudan, M. Harris.
Identification of CXCR5⁺EBV-Specific CD8⁺ T Cells in Peripheral Blood of Pediatric Heart Transplant Recipients Correlates With IL-21 Production and EBV Reactivation

C. Macedo,¹ K. Hadi,¹ D. Rowe,² J. Luce,³ S. Webber,⁴ B. Feingold,³ D. Metes.¹
Identification of Genetic Variants Associated With Variation of Tacrolimus Levels in African Americans Using GWAS

W. Oetting,¹ D. Schladt,² W. Guan,¹ A. Israni,² R. Remmel,¹ C. Dorr,² K. Sanghavi,¹ R. Mannon,³ B. Herrera,⁴ A. Matas,¹ D. Salomon,⁵ P. Kwok,⁴ P. Jacobson,¹ for DeKAF Genomics.¹
Identification of miRNAs Associated With Induced Tolerance to Allografts

M. Vitalone, L. Wei, C. Esquivel, S. Busque, O. Martinez, S. Krams.
Identification of Mouse Tolerogenic B Cells Expressing PD-L1/PD-L2 in B-1a Subset

T. Hirose,^1,2 Y. Tanaka,¹ H. Sakai,¹ Y. Sasaki,¹ H. Ohdan.¹
Identification of Strategies to Facilitate Organ Donation Among African Americans

J. Locke,¹ H. Qu,² R. Shewchuk,² D. Segev,³ M. Martin.⁴
Identifying Barriers Specific to Xenoislets by Direct Comparison to Alloislets in a Dual Transplant Model

K. Samy,¹ B. Martin,² P. Thompson,² A. Farris,² M. Song,² V. Leopardi,¹ B. Collins,¹ A. Kirk.¹
Identifying Predictors for 30-Day Readmission in Renal Transplant Recipients

J. Weber,¹ B. Astor,² D. Cray,³ A. Djamali,² D. Kaufman,⁴ D. Mandelbrot,² S. Parajuli,² M. Schanning,³ E. Snyder,¹ M. Mohamed.²
Identifying Predictors of Organ Donation Among African-American Men

C. Harris,¹ C. Modlin,¹ S. Olden,² A. Nowacki,³ T. Franklin,⁴ J. Canedy,¹ M. Tavaras,¹ A. Harris,¹ Y. Hamilton,⁵ C. Zaramo.¹
Identifying the “Operational Tolerant” Pediatric Liver Transplant Recipient by Cytometry by Time-of-Flight

A. Lau,^1,2 M. Vitalone,¹ K. Haas,³ T. Shawler,¹ C. Esquivel,¹ O. Martinez,¹ R. Castillo,³ S. Krams.¹
IFNγ Is Required for nTreg Afferent Lymphatic Migration

S. Ahmad, Y. Xiong, C. Brinkman, J. Bromberg.
IgM+ Antigen Binding B Cells in Peripheral Blood Regulate IFNγ Production in Response to HLA Proteins

L. McLaughlin,¹ K. Shiu,¹ G. Lombardi,¹ J. Spencer,² R. Vaughan,¹ A. Dorling.¹
IL-17 Production Influenced by Induction Therapy With ATG

D. Abendroth,¹ M. Marzinzig,¹ J. Kaden.²
IL-2-Dependent Natural Killer Cell Responses to Epstein-Barr Virus B Cell Lymphomas Involve the NKG2A/NKG2C Axis

O. Hatton, D. Strauss-Albee, C. Blish, C. Esquivel, S. Krams, O. Martines.
IL-2/IL-2 Ab Complex Leads to Long-Term Tolerance in a Treg Dependent DST Model of Skin Allograft Transplantation in Which DST and Timing of the Antibody Complex Are Crucial

G. Zhang,¹ Y. Wang,¹ M. Hu,¹ A. Sawyer,¹ J. Zhou,¹ S. Grey,² S. Alexander.¹
IL-21 Regulates Creation of Tertiary Lymphoid Organs in Chronic Allograft Rejection

C. Baum,¹ M. Khattar,² P. Schroder,¹ W. Chen,³ S. Stepkowski.¹
IL-33 Enhances Host Tolerance to Candida albicans Kidney Infections Through Induction of IL-13 Production by CD4⁺ T Cells

H. Cho,^1,2 J. Lee,^2,3 V. Tran,⁴ H. Kim,^2,4 J. Kim,^2,4 B. Kwon.^2,4
ILC1 and ILC3 Are the Predominant Intra-Epithelial Lymphoid Populations in Human Small Bowel Grafts

P. Talayero,¹ E. Mancebo,¹ J. Calvo-Pulido,² S. Rodriguez-Muñoz,³ A. García-Sesma,² C. Loinaz,² C. Jiménez,² F. Cano,¹ R. Laguna,¹ E. Paz-Artal.¹
Immune Phenotyping of Peripheral Blood Samples from the CTOT-10 Belatacept Study

Y. Suessmuth,¹ L. Stempora,¹ B. Johnson,¹ J. Cheeseman,¹ Y. Morrison,⁴ N. Bridges,⁴ D. Ikle,⁵ S. Tomlanovich,³ P. Stock,³ R. Mannon,² K. Newell,¹ C. Larsen,¹ A. Mehta.¹
Immune Reconstitution in Recipients of Living Donor Kidney/Hematopoietic Stem + Facilitating Cell Transplants

J. Leventhal,¹ M. Elliott,² E. Yolcu,² L. Bozulic,³ D. Tollerud,³ J. Mathew,¹ I. Konieczna,¹ M. Ison,¹ M. Badder,³ M. Abecassis,¹ J. Miller,¹ L. Gallon,¹ S. Ildstad.³
Immune Rejection of iPS Cells Is Triggered By Gamete-Associated Proteins (GAPs)

E.-M. Kim, G. Manzar, N. Zavazava.
Immune Response to Kidney and Pancreas Self-Antigens Are Associated With Antibody Mediated Rejection in Simultaneous Kidney Pancreas Transplants

M. Gunasekaran,¹ A. Siddiq,² S. Shenoy,¹ J. Wellen,¹ T. Mohanakumar.¹
Immune-Mediated Injury in Kidney Transplant Recipients Treated With Alemtuzumab Induction and a Steroid Avoidance Protocol

R. Sapir-Pichhadze, T. Mahbub, C. Saw, D. Baran.
Immunodeficiency Assessment in Pediatric Intestinal Failure Patients

J. Garcia,¹ T. Beduschi,¹ C. Biaggi,² E. Perez,² A. Tekin,¹ M. McGetrick,³ L. Cubley,¹ P. Ruiz,¹ J. Fan,¹ S. Nishida,¹ G. Selvaggi,¹ R. Vianna.¹
Immunoglobulin G Donor-Specific Anti-HLA Antibody Subclasses and Kidney Allograft Antibody-Mediated Injury

D. Viglietti,^1,2 C. Bentlejewski,³ J.-P. Duong van Huyen,^4,2 D. Vernerey,^5,2 O. Aubert,² J. Verine,¹ X. Jouven,² C. Legendre,⁴ D. Glotz,¹ A. Loupy,^2,4 A. Zeevi,³ C. Lefaucheur.^1,2
Immunologic Long-Term Outcome of Living Kidney Transplantation Depending On the Donor-Recipient Relationship

D. Khadzhynov, F. Halleck, D. Schmidt, S. Kreimer, K. Budde, O. Staeck.
Immunologic Outcomes in Elderly Kidney Transplant Recipients

D. Khadzhynov, F. Halleck, L. Liefeldt, P. Glander, J. Bamoulid, S. Kreimer, L. Lehner, K. Budde, O. Staeck.
Immunologic, Proangiogenic and Neurogenic Assessment of Allogenic Epineurium of the Human Peripheral Nerve for Potential Application in Prevention of Neuroma Formation

A. Klimczak,¹ K. Futoma,² A. Jundzill,³ D. Patrzalek,⁴ M. Siemionow.⁵
Immunological Aspects of Iron Overload in Heart and Kidney Transplantation

T. Resch,¹ S. Ebner,¹ P. Ritschl,¹ M. Ashraf,¹ C. Fabritius,¹ A. Brunner,² V. Nguyen,¹ J. Günther,¹ J. Pratschke,³ K. Kotsch.¹
Immunological Characterization of Full Facial Transplant Recipients

T. Borges,¹ J. Azzi,¹ S. Tullius,¹ A. Chandraker,¹ B. Pomahac,² N. Najafian,¹ L. Riella.¹
Immunological Evaluation of Acellular Extracellular Matrix Upon Transplantation

M. Ketaki,¹ P. Pradeep,¹ N. Nikhil,¹ G. Dellgren,³ H. Suchitra, M. Olausson.²
Immunomodulation of Human T Cells by a Novel RALG Preparation With Higher Specificity Toward Activating T Cells

K. Samy, H. Xu, A. Kirk.
Immunomodulatory Effects of Neuropilin-2 On T Cells

H. Nakayama,^1,2 N. Kochupurakkal,¹ S. Bruneau,¹ D. Bielenberg,² M. Klagsbrun,² D. Briscoe.¹
Immunomodulatory Strategies Directed Towards Tolerance of Vascularized Composite Allografts

M. Madariaga, K. Shanmugarajah, S. Michel, V. Villani, G. La Muraglia II, R. Torabi, D. Leonard, M. Randolph, R. Colvin, K. Yamada, J. Madsen, C. Cetrulo, Jr., D. Sachs.
Immunomonitoring By Virus-Specific T Cells After Pediatric Kidney Transplantation (IVIST01-Trial): Study Design and Status

T. Ahlenstiel-Grunow,^1,4 M. Sester,³ U. Sester,² L. Pape.^1,4
Immunosuppression and Reoperation After Simultaneous Kidney Pancreas Transplantation Convey Greatest Risk for Rejection

C. Bratton, V. Rohan, S. Nadig, J. Mcgillicuddy, K. Chavin, P. Baliga, D. Taber.
Immunosuppression With Anti-CD40 mAb and Rapamycin for Islet and Kidney Co-Transplantation in Nonhuman Primates

T. Oura, K. Hotta, J. Lei, J. Markmann, A. Dehnadi, G. Benichou, B. Cosimi, T. Kawai.
Impact of HMOX1 Genetic Variation in Pancreas Transplant Recipients On Long-Term Graft Outcome

C. Duff,¹ A. Hamilton,¹ S. Mittal,^2,3,4 M. Barnardo,^2,3 S. Fuggle,^2,3 P. Friend,^2,3 S. Gough,^1,4 M. Simmonds.¹
Impact of Abdominal Aortic Calcification in Living Kidney Donors

Y. Yoon,¹ K. Choi,² D. Joo,³ K. Huh,³ M. Kim,³ S. Kim,³ Y. Kim,³ S. Yang,² W. Han.¹
Impact of Alloreactivity On Intra-Graft T Cell Homeostasis Following Small Bowel Transplantation

J. Zuber, B. Shonts, S. Lau, S. Coley, S. Yang, J. Weiner, S. DeWolf, D. Farber, Y. Shen, M. Martinez, T. Kato, M. Sykes.
Impact of Anatomic Variation and Reconstructive Technique on Complications Following Living Liver Donor Transplantation – A Report from the A2ALL Consortium

T. Baker,¹ M. Zimmerman,² B. Samstein,³ E. Pomfret,⁴ J. Pomposelli,⁴ C. Berg,⁵ N. Goodrich,⁶ B. Gillespie,⁷ J. Emond.³
Impact of Anti-CMV Prophylactic Therapy on the Development of CMV Quantiferon Sero-Conversion in High-Risk Patients

A. Palanisamy, D. Taber, N. Pilch, C. Bratton, J. McGillicuddy, P. Baliga, K. Chavin.
Impact of Baseline and Postoperative Isoagglutinin Titer on Clinical Outcomes in ABO-Incompatible Living Donor Kidney Transplantation

E. Shin,¹ H. Cho,¹ H. Kim,¹ C. Baeck,¹ H. Yu,¹ D. Han,² S.-K. Park.¹
Impact of Cold Ischemic Time (CIT) and Distance Traveled (DT) on Shipped Kidneys in the OPTN/UNOS Kidney Paired Donation (KPD) Pilot Program (PP)

M. Aeder,¹ D. Stewart,² R. Leishman,² L. Robbins Callahan,² A. Kucheryavaya,² T. Sandholm,³ R. Formica.⁴
Impact of Community Risk on Early Hospital Readmission Following Kidney Transplant

E. King,¹ L. Kucirka,¹ M. McAdams-DeMarco,^1,2 A. Massie,^1,2 J. Schold,³ D. Segev.^1,2
Impact of CXCR4/CXCL12 Blockade on Normal Plasma Cells In Vivo

N. Moore,¹ M. Moreno Gonzales,² M. Stegall.¹
Impact of Delayed Graft Function and Number of Dialysis Sessions on Graft Outcome After Kidney Transplantation

L. Lehner, A. Hohberger, L. Marschke, K. Zhang, F. Halleck, D. Khadzhynov, O. Staeck, M. Dürr, D. Schmidt, L. Liefeldt, K. Budde.
Impact of Donor Age on Longterm Outcomes in Asian Kidney Transplant Recipients: A Multicenter Cohort Study

K. Yoo,¹ J. An,² J.-H. Cho,³ C.-D. Kim,³ S.-K. Park,⁴ D.-W. Chae,⁵ Y. Oh,² C. Lim,² Y. Kim,¹ Y. Kim,⁶ J. Lee.²
Impact of Donor and Recipient BKV Serostatus and the Effect of Ciprofloxacin Prophylaxis on BK Viremia Risk After Kidney Transplant

M. Changala,¹ A. Kistler,² J. Abend,² A. Sathe,² A. Howard,¹ D. Wojciechowski.¹
Impact of Donor Hemoglobin A1c On Pancreas Graft Survival

K. Collins,¹ J. Garonzik-Wang,¹ E. King,² M. Doyle,¹ J. Lowell,¹ S. Shenoy,¹ Y. Lin,¹ J. Wellen,¹ W. Chapman,¹ D. Segev.²
Impact of Donor Post-Extubation O2 Delivery on Recipient Hypoxic Cholangiopathy in Donation After Circulatory Death Liver Transplantation: The University of Colorado Experience

T. Chirichella,¹ C. Dunham,² M. Zimmerman,⁴ K. Conzen,¹ S. Kelley,³ E. Phelan,¹ T. Steinberg,¹ T. Nydam,¹ T. Bak,¹ I. Kam,¹ M. Wachs.¹
Impact of Donor Specific Antibodies in the Older Kidney Transplant Recipient

S. Patel, J. Loucks-DeVos, R. Knight, S. Kuten, L. Gaber, A. Gaber.
Impact of Early Urinary Tract Infections on Renal Graft Function

J. Rago, L. Bowman, D. Brennan, J. Hagopain, T. Horwedel.
Impact of Educational Attainment On Kidney Transplant Outcomes By Race

A. Aguirre-Alarcon,¹ P. Friedmann,¹ A. Gregg,² L. Kayler.³
Impact of Elevated BMI on Allograft Outcomes: A Competing Risks Regression Analysis

A. Naik, A. Sakhuja, M. Samaniego, P. Shrivastava, D. Cibrik.
Impact of Everolimus On the Hepatocellular Carcinoma Recurrence After Living Donor Liver Transplantation When Used in Early Stage: A Single Center Prospective Study

L. Jeng, A. Thorat, H. Yang, C.-C. Yeh, T.-H. Chen, S.-C. Hsu.
Impact of HLA Antibody Monitoring After Kidney Transplantation

S. Rao,¹ M. Ghanta,¹ H. Parekh,² A. Gillespie,¹ I. Lee,¹ S. Geier,² K. Lau,³ S. Karhadkar,³ A. Di Carlo,³ S. Constantinescu.¹
Impact of Human Mutant TGF-β1/Fc Protein On Memory and Regulatory CD4+T Cells Following Lymphodepletion in Rhesus Monkeys

H. Guo,¹ L. Lu,¹ R. Wang,² H. Abdulkerim,² R. Keith,² A. Thomson,¹ M. Ezzelarab.¹
Impact of Induction Therapy on Outcomes in HIV + Renal Transplant Recipients

C. Kershaw,¹ C. Rogers,^2,4 M. Pavlakis,^1,2 H. Tang,² C. Alonso,^1,2 K. Khwaja,^2,3 A. Evenson,^2,3 K. Raven,^2,3 M. Wong.^1,2
Impact of Integrase Inhibitor-Based Antiretroviral Regimen on Outcomes in HIV + Renal Transplant Recipients

C. Kershaw, C. Rogers, M. Pavlakis, H. Tang, C. Alonso, K. Khwaja, A. Evenson, K. Raven, M. Wong.
Impact of Machine Perfusion After Long Static Cold Storage On Delayed Graft Function Incidence and Duration and Time to Hospital Discharge

A. Matos,¹ M. Borrelli, Jr.,¹ L. Moura Requiao,¹ M. Nogueira, Jr.,¹ L. Pertusier,¹ G. Clarizia,¹ P. Ongaro,¹ S. Ximenes,¹ M. Durao, Jr.,^1,2 A. Pacheco-Silva.^1,2
Impact of Positive Crossmatch Due to Non-HLA Antibodies on Graft Outcomes in Renal Transplantation

S. Kuten, S. Patel, G. Land, T. Eagar, R. Knight, J. Loucks, L. Gaber, A. Gaber.
Impact of Pre-Transplant Panel Reactive Antibody Levels On Renal Graft Survival in Patients With Negative Cross-Match and No Donor Specific Antibody

K. Jun,¹ M. Kim,¹ H. Kim,¹ K. Park,² S. Ahn,¹ J. Hwang,¹ S. Kim,¹ S. Park,¹ S. Kim,¹ J. Kim,¹ I. Moon.¹
Impact of Preoperative MELD Score On Small for Size Syndrome in Living Donor Liver Transplantation

S. Marubashi, A. Tomokuni, Y. Tomimaru, T. Asaoka, H. Wada, H. Eguchi, K. Umeshita, Y. Doki, M. Mori, H. Nagano.
Impact of Pretransplant Pregnancy On Immunization and Immunologic Outcome in Kidney Transplantation

O. Staeck,¹ D. Khadzhynov,¹ S. Kreimer,¹ E. Rajakangas,¹ C. Schönemann,² N. Lachmann,² K. Budde,¹ F. Halleck.¹
Impact of Pretransplant Sarcopenia and Sequential Changes in Sarcopenic Parameters After Living Donor Liver Transplantation

T. Kaido,¹ Y. Tamai,² K. Ogawa,¹ Y. Fujimoto,¹ A. Mori,¹ H. Okajima,¹ N. Inagaki,² S. Uemoto.¹
Impact of Proton Pomp Inhibitors on Hypomagnesemia and Arterial Stiffness in Renal Transplant Recipients

S. Sezer,¹ B. Gurlek Demirci,¹ M. Erkmen Uyar,¹ S. Uyanik,² M. Haberal.³
Impact of Serial Change of Donor Specific Antibodies On the Graft Outcomes After Liver Transplantation

D. Joo,^1,2 J. Lee,³ J. Lee,^1,2 J. Lee,^1,2 S. Kim,⁴ D. Han,^1,2 M. Ju,^1,2 J. Choi,^1,2 S. Kim,^1,2 M. Kim.^1,2
Impact of Sirolimus on the Risk of BK Viremia in Simultaneous Pancreas-Kidney Transplant Recipients

D. Wojciechowski, T. Yokoyama, S. Chandran, P. Stock.
Impact of Subclinical Rejection (SCR) and Acute Clinical (ACR) in Renal Transplant Recipients

R. Mehta, P. Sood, A. Cherukuri, S. Chen, G. Mour, C. Wu, N. Shah, C. Puttarajappa, P. Randhawa, A. Tevar, S. Hariharan.
Impact of Type of Tacrolimus Assay on Therapeutic Drug Monitoring: Need for Standardization

M. Singh, S. Anwar, D. Brennan, R. Delos Santos.
Impacts of Mycophenolate Mofetile Addition to Very Low Exposure Everolimus and Calcineurine Inhibitor Based Immunosuppression in De Novo Kidney Transplantation

Y. Watarai,¹ M. Okada,¹ K. Futamura,¹ K. Ito,¹ T. Yamamoto,¹ M. Tsujita,¹ T. Hiramitsu,¹ N. Goto,¹ S. Narumi,¹ T. Kobayashi.²
Impaired Autophagy: A Mechanism of Fatty Liver Increases Susceptibility to Ischemia Reperfusion Injury

Q. Zhao, Z. Guo, W. Ju, L. Wu, D. Wang, Y. Ma, M. Chen, R. Deng, X. He.
Implementation of Evidence-Based Guidelines for Cytomegalovirus Prevention in Pediatric Solid Organ Transplantation

L. Danziger-Isakov, T. Hemmelgarn, R. Kohli, D. Lazear, M. Lake, J. Goebel, C. Castleberry, J. Courter, S. Kacoshis, M. Schecter, D. Witte, E. Clark, J. Bucuvalas.
Implementation of Pre-Transplant Infectious Disease Risk Assessment: Sustained Success With Rapid-Cycle Improvement

L. Danziger-Isakov, S. Blum, D. Dahale, B. Morrow, R. Rengering, D. Schoborg, S. Stark, E. Wells, A. Lorts, U. Kotagal, J. Bucuvalas.
Implication of Intragraft γδ T Cell Profiles in Operational Tolerance After Clinical Transplantation of Highly Immunogenic Intestine -Difference from Immunoprivileged Liver

Y. Li,¹ X. Zhao,¹ H. Ohe,² H. Nafady-Hego,³ A. Bishop,⁴ J. Pirenne,⁵ T. Koshiba.⁶
Implications of Living Donor Kidney Histology, Volume and Function on Post-Donation GFR

Z. Zaky,¹ B. Lankowsky,² S. Shah,¹ L. Herlitz,¹ A. Chiesa-Vottero,¹ K. Wallenfelsz,¹ A. Caplin,¹ D. Goldfarb,¹ S. Flechner,¹ J. Schold,¹ E. Poggio.¹
Implications of Living Kidney Donor Histology, Volume and Function on Allograft Outcome

S. Shah,¹ B. Lankowsky,² L. Herlitz,³ A. Chiesa-Vottero,³ Z. Zaky,¹ D. Goldfarb,⁴ S. Flechner,⁴ E. Poggio.¹
Import Pancreas Transplants: Good from Far or Far from Good?

J. Rogers, A. Farney, G. Orlando, A. Reeves-Daniel, A. Palanisamy, H. El-Hennawy, M. Khan, M. Gautreaux, S. Iskandar, R. Stratta.
Improved Bioavailability and Reduced Dose Requirements of Novel, Once-Daily, MeltDose® Tacrolimus Formulation Tablets (Envarsus® XR) Compared to Twice-Daily Tacrolimus Capsules (Prograf®) in De Novo Kidney Transplantation: Results of a Phase 3 Double-Dummy, Randomized Trial

J. Grinyó,¹ S. Bunnapradist,² S. Mulgaonkar,³ S. Steinberg.⁴
Improved Long-Term Graft Survival in Renal Transplant Recipients With Donor Specific Antibodies (DSA) After Mycophenolic Acid Escalation

L. Rebellato,¹ K. Parker,² F. Rana,³ S. Kendrick,⁴ C. Morgan,⁵ C. Haisch,⁵ M. Everly,⁶ R. Harland,⁵ P. Bolin.³
Improved Renal Function Post-Liver Transplant With Earlier Everolimus Conversion

S. Lin,¹ M. Zimmerman,² V. Lewis,¹ S. Biggins,³ C. Ruller,⁴ I. Kam,⁴ T. Nydam.⁴
Improving ABMR Diagnostics Through Advanced Anti-HLA Antibody Screening Techniques

R. Ponsirenas,^1,2 H. Cazarote,^1,2 S. Shimakura,³ J. Valdameri,¹ F. Contieri,⁴ C. von Glehn,^1,2 M. Susin.^1,2
Improving Latent Tuberculosis Diagnosis Before Kidney Transplantation in a Developing Country

G. Meinerz,^1,2 C. da Silva,^1,2 E. Keitel,^1,2 A. Pasqualotto,³ J. Goldani,^1,2 C. Zeni,^1,4 F. Vacilotto,^1,4 N. Prado,^1,4 A. Monteiro,^2,3 D. Seelig,¹ F. Klaus,¹ J. Andrade,¹ V. Garcia.¹
Improving the Predictive Value of the Virtual Crossmatch: Is the C1Q Assay Needed?

A. Colovai,¹ C. Savchik,¹ P. Masiakos,¹ S. Calp-Inal,² L. Kayler,³ E. Akalin.²
In House Oxygen Persufflation of Cold Stored Livers Versus Simple Cold Storage in Extended Criteria Liver Grafts: Results of a Randomized Controlled Clinical Trial

A. Gallinat,¹ A. Paul,¹ D. Hoyer,¹ C. Klein,¹ S. Swoboda,¹ C. Ose,² Z. Mathe,¹ J. Treckmann,¹ T. Minor.³
In Pre-Implantation Biopsies Expression of Micro RNAs Is Not a Good Surrogate for Established mRNA Markers of Kidney Injury

K. Famulski,¹ S. Niederhaus,² J. Reeve,¹ J. Bromberg,² P. Halloran.¹
In Vitro Evidence That CTLA4Ig Attenuates Recall Alloantibody Responses

I. Kim,¹ G. Wu,¹ N.-N. Chai,¹ S. Jordan,² A. Klein.¹
In Vivo Expansion of Donor-Specific Regulatory T Cells by a New Triazolopyrimidine Derivative and Donor-Specific Transfusion

S. Emoto,¹ R. Goto,¹ S. Shibasaki,¹ A. Nagatsu,¹ H. Ono,¹ R. Igarashi,¹ M. Fukai,² T. Shimamura,³ K. Saiga,⁴ M. Murakami,⁵ A. Taketomi,¹ S. Todo,⁶ K. Yamashita.²
Inadequate Overall Immunosuppression Is a Risk for Late Acute Rejection Despite Alemtuzumab Induction in Simultaneous Pancreas Kidney Transplant Recipients

J. Bank,¹ M. Mallat,¹ P. van der Boog,¹ D. Braat,² J. Ringers,² M. Vergunst,³ S. Heidt,³ F. Claas,³ M. Reinders,¹ J. de Fijter.¹
Incidence and Characteristics of CMV Infection in High Risk (D+R-) Kidney Transplant Recipients and the Utility of Monthly Surveillance After Routine Prophylaxis

M. Bhattarai, C. Puttarajappa, G. Mour, C. Wu, P. Sood, N. Shah, R. Mehta, A. Tevar, S. Hariharan.
Incidence and Clinical Severity of Hypogammaglobulinemia (Hypo-IgG) in Highly-HLA Sensitized Patients (HS) Undergoing Desensitization (DES)

A. Vo,¹ S. Ge,² A. Petrosyan,² M. Toyoda,² J. Choi,¹ J. Kahwaji,¹ A. Peng,¹ R. Villicana,¹ S. Jordan.¹
Incidence and Impact of De Novo Donor-Specific Anti-HLA Antibodies in ABO-Compatible Liver-Transplant Recipients

A. Del Bello,^1,2 N. Congy-Jolivet,^2,3,4 D. Milongo,¹ C. Guilbeau-Frugier,^2,5 L. Lavayssière,¹ F. Muscari,^2,6 L. Rostaing,^1,2,7 N. Kamar.^1,2,7
Incidence and Outcomes of Polyomavirus Infection in 639 Kidney Transplant Recipients: Are High Immunological Risk Characteristics More Relevant Than Specific Induction Or Maintenance Immunosuppressive Regimens?

E. Favi,¹ L. Harris,² J. Worsfold,² R. Cacciola,¹ C. Puliatti,¹ C. Sammartino,¹ R. Sivaprakasam.¹
Incidence and Risk Factors for Emergency Department Visits Following Kidney Transplantation

N. Elfadawy,^1,2 E. Poggio,¹ D. Goldfarb,¹ L. Buccini,¹ S. Flechner,¹ J. Schold.¹
Incidence and Risk Factors for Infectious Complications in Liver Transplant Patients Converted to Everolimus

A. Islam,¹ J. DeVos,² L. Teeter,³ E. Graviss,³ S. Gordon-Burroughs,¹ A. Saharia,¹ C. Mobley,¹ A. Gaber,¹ R. Ghobrial.¹
Incidence and Risk Factors of Contrast-Induced Nephropathy in Renal Allograft Recipients

B. Abu Jawdeh, Y. Sharma, S. Katipally, A. Leonard, R. Alloway, E. Woodle, C. Thakar.
Incidence and Risks Associated With Clostridium Difficile Infection in the Pediatric Solid Organ Transplantation Population: A Single-Center Retrospective Review

L. Danziger-Isakov,¹ J. Ciricillo,² S. Blum,¹ M.-O. Kim,¹ C. Liu,¹ G. Paulsen,¹ J. Courter,¹ D. Haslam.¹
Incidence of CMV Viremia in Obese and Morbidly Obese Kidney Transplants Under a Low Dose Valganciclovir Prophylaxis Protocol

J. Thielke,¹ P. West-Thielke,² E. Benedetti.²
Incidence of De Novo Donor Specific Antibodies in Kidney Transplant Recipients

C. Staino, N. Pilch, O. Moussa, K. Boyle, J. Casale, K. Covert, J. Fleming, D. Taber, H. Meadows, C. Mardis, K. Chavin, S. Nadig, J. McGillicuddy, C. Bratton, T. Srinivas, P. Baliga.
Incidence of Hepatitis B Virus Reactivation in Kidney Transplant Patients Who Received Rituximab Administration

K. Omoto, M. Okumi, D. Toki, T. Shimizu, H. Ishida, K. Tanabe.
Incidence, Determinants and Outcome of Kidney Transplantation for End Stage Renal Disease After Heart Transplantation

A. Grupper,¹ A. Grupper,¹ R. Daly,¹ M. Hathcock,² W. Kremers,² F. Cosio,¹ B. Edwards,¹ S. Kushwaha.¹
Incidence, Risk Factors, and Outcomes of Hospitalized Urinary Tract Infections in Kidney Transplant Recipients

H. Pang, C. Liang, O. Famure, Y. Li, J. Kim.
Incidence, Timing, and Consequence of De Novo Donor Specific Antibody in Intestinal Transplantation

C. Matsumoto, J. Hawksworth, S. Kozlowski, S. Rosen-Bronsen, A. Kromer, M. Grafals, N. Yazgi, S. Kaufman, K. Khan, R. Girlanda, E. Island, C. Desai, T. Fishbein.
Incisional Herniation Following Hand Assisted Laparoscopic Donor Nephrectomy: Incidence, Impact and Aetiology

Z. Ahmed, I. Mosca, M. Dirix, R. Tamburrini, N. Kessaris, N. Mamode.
Incorporating Markers of Donor Organ Intrinsic Biology Into Donor Quality Evaluation

J. Suh, K. Archer, L. Gallon, I. McConell, A. King, D. Maluf, V. Mas.
Increase in Neurologic Determination of Death (NDD) Organ Donation in the Donation After Circulatory Death (DCD) Era. The Ontario Experience

J. Zaltzman,^1,2 J. MacLean,² C. Payne,² E. Paltser,² V. Rao,³ S. Dhanani.^2,4
Increased Cytotoxic and Regulatory T Cell and B Cell Associated Gene Transcripts in Transplant Kidney Biopsies With Non-Specific IFTA and Interstitial Inflammation

S. Akten, M. Ajaimy, P. O Broin, Y. Bao, A. Golden, E. Akalin.
Increased Fibroblast Growth Factor 21 Levels in Biliary Atresia Patients

D. Li, T. Lu, Y. Shan, C. Shen, X. Hua, M. Zhang, Q. Xia.
Increased Frequency of Terminally Differentiated and Exhausted CD8+ T Cells Is Associated With Adverse Clinical Outcome After Mechanical Circulatory Support Device Implantation

J. Schaenman,¹ Y. Korin,² T. Sidwell,² G. Sunga,² G. Bondar,³ N. Wisniewski,³ M. Kwon,⁴ M. Cadeiras,³ M. Deng,³ E. Reed.²
Increased Late Graft Loss in Kidney Recipients With Serum Sickness Disease Following Anti-Thymocyte Globulin Induction: Relation With an Anti-Neu5Gc Response

A. Salama,^1,2 G. Couvrat-Desvergnes,¹ M. Lorent,^1,3 G. Evanno,¹ L. Le Berre,¹ P. Hruba,⁴ P. Vesely,⁵ P. Guerif,¹ A. Nicot,¹ J.-M. Bach,⁶ Y. Foucher,^1,3 S. Brouard,¹ S. Castagnet,⁷ O. Viklicky,⁴ M. Giral,¹ J. Harb,¹ S. Jean-Paul.¹
Increased Length of Stay After Heart Transplant: What Are the Risk Factors?

A. Velleca, M. Kittleson, N. Perry, J. Patel, F. Liou, S. Siddiqui, J. Rush, D. Ramzy, L. Czer, D. Chang, J. Kobashigawa.
Increased Precentage of Circulating CD16+ Monocytes Before Transplantation Are Associated With the Occurence of Acute Rejection

T. van den Bosch,¹ L. Hilbrands,² M. Kraaij,¹ E. Vereyken,¹ P. Leenen,³ D. Hesselink,¹ C. Baan,¹ A. Rowshani.¹
Increased Ratio of Estimated Spleen/Graft Volume Is a Strong Predictor of Posttransplant Portal Hypertension in Adult-To-Adult Living Donor Liver Transplantation: Significance of Splenectomy On Portal Venous Pressure and Patient Survival

S. Mizuno, K. Gyoten, A. Tanemura, Y. Murata, H. Kato, N. Kuriyama, M. Kishiwada, M. Usui, H. Sakurai, S. Isaji.
Increased Risk of VRE Infection in Liver Transplant Patients With MELD of 35 or Greater

A. Nelson,¹ R. Girlanda.²
Increased Use of Donors After Cardiac Death (DCD) in Pancreas Transplantation: A Safe and Effective Way to Increase a Single Center Program Activity

M. Marquez, G. Sapisochin, J. Laurence, A. Barbas, M. Dib, A. Norgate, M. Selzner, P. Greig, I. McGilvray, M. Cattral.
Increased Vascular Stiffness in Pediatric Renal Transplant Recipients Despite Normal Kidney Function, Blood Pressure, and Body Mass Index

M. Seifert,^1,2 N. Kulsum-Mecci,² L. de las Fuentes,² V. Davila-Roman,² K. Hruska.²
Increasing Tacrolimus Exposure to Minumize Chronic Rejection: How Can We Do It? What Are the Risks?

T. Hsu,¹ J. Yin,¹ L. Awdishu,¹ J. Kerr,¹ R. Steiner.²
Increasing the Number of Organ Transplants in the United States by Optimizing Donor Authorization Rates

D. Goldberg,¹ B. French,² P. Abt,³ R. Gilroy.⁴
Indefinite Survival of Fully MHC-Mismatched Murine Cardiac Allografts by Combination of Anti-BTLA mAb (6B2) and Anti-PD-1 mAb (PIM-2)

E. Yin,^1,2 M. Uchiyama,^1,3,4 X. Jin,^1,5 T. Shimokawa,³ H. Yagita,⁴ M. Niimi.¹
Independent Prognostic Factors for Survival in Hepatocellular Carcinoma Patients Undergoing Orthotopic Liver Transplantation: UNOS Population Study

M. Xing, H. Kim.
Induction Avoidance in 2-Haplotype-Matched White Living Kidney Transplantation

Z. Brifkani,¹ T. Alhamad,¹ T. Horwedel,² R. Delos Santos,¹ T. Maw,¹ D. Brennan.¹
Induction of a Costimulation-Susceptible Repertoire: A Case for Depletional Prior to Belatacept

H. Xu,¹ K. Samy,¹ A. Guasch,² S. Mead,² A. Kirk.¹
Induction of HO-1 High Expression Enhances the Capacity of Immature Dendritic Cells to Modulate Alloimmune Responses

G. Chen, Y. Zhao, L. Wang, S. Chen, X. Huang.
Induction of iNOS Expressed Macrophages from Mouse iPS cells That Contribute to Prolong Same iPS Cells-Derived Graft Survival in Allogeneic Recipients

H. Sasaki,¹ H. Wada,² K. Morita,¹ K.-I. Seino,² N. Shinohara.¹
Induction Therapy (IT) in Simultaneous Pancreas and Kidney Transplantation (SPK) according to Patient Risk – A Registry Analysis

R. Gruessner,¹ A. Gruessner.²
Induction Therapy Improves 15-Year Graft Survival in Kidney Transplant Recipients With Acute Rejection

R. Bajoka, M. Goggins, A. Patel.
Induction Therapy With either Anti-Thymocyte Antibodies or Il2 Receptor Inhibitors Appears to Decrease the Risk of Graft Loss in DCD Liver Transplantation Compared to No Induction Therapy

S. Rayhill, J. Haldorson, A. Dick, S. Nazarian, L. Sibulesky, M. Montenovo, L. Yu, I. Javid, T. Pearson, R. Bakthavatsalam, P. Healey, J. Perkins, J. Reyes.
Induction With an Interleukin-2 Receptor Antagonist in Sensitized Adult Kidney Transplant Recipients Is Highly Effective and Safe

J. Casale, J. Fleming, D. Taber, C. Staino, K. Boyle, K. Covert, N. Pilch, H. Meadows, C. Mardis, K. Chavin, C. Bratton, J. McGillicuddy, P. Baliga.
Induction With ATG Is Not Associated With Increased Infections After Kidney Transplant Among HIV Positive Patients: Results of a National Study

L. Kucirka,¹ C. Durand,¹ S. Bae,¹ J. Locke,² D. Segev.¹
Industry Payments to Transplant Surgeons

R. Ahmed, E. Chow, A. Massie, E. King, B. Orandi, S. Bae, L. Nicholas, B. Lonze, D. Segev.
Infections After Alemtuzumab Induction: A Non Issue?

A. Smith, M. John, I. Dortonne, A. Paramesh, M. Killackey, R. Zhang, B. Lee, J. Buell.
Infections After Transplant Tourism in Organ Transplant Recipients

D. Kumar,¹ A. Humar,¹ H. Crossman,² C. Kotton,³ M. Levi.²
Infectious Complications in ABO Incompatible Kidney Transplantation Recipient According to the Rituximab Dose

J. Lee,¹ J. Lee,¹ S. Kim,² M. Ju,¹ D. Joo,¹ M. Kim,¹ S. Kim,¹ Y. Kim,¹ H. Kim,² K. Huh.¹
Infectious Complications With Plasmapheresis in Combination With Antithymocyte Globulin Compared to Antithymocyte Globulin Alone in the Treatment of Acute Rejection

A. Leino, A. Hulbert, A. Delahunty, A. Rajab, J. Von Visger, H. Winters.
Inflammasome Activation in Hepatocytes and Kupffer Cells Orchestrates the Hepatotoxic Effect of Bile Acids and Can Be Potential Target in the Management of Cholestatic Liver Injury

X. Liu,¹ T. Ma,¹ T. Billiar,² R. Tao.¹
Inflammation in Regions of Tubular Atrophy (IATR) Predicts Adverse Graft Outcome in Patients With Late Graft Dysfunction: A Multicenter Study

J. Grande,¹ R. Leduc,³ A. Matas.²
Inflammatory Profiling of Hypothermic Machine Pumped Kidney Allografts

J. Cohen, E. Ratigan, A. Shigeoka, R. Steiner, L. Stocks, D. McKay.
Influence of Cold Ischemia Time in Combination With Donor Ischemic Events on Kidney Transplant Outcomes

M. Lubetzky, Y. Xia, P. Friedmann, C. Cortes, L. Kayler.
Influence of CYP3A5 and ABCB1 Genotypes on Pharmacokinetics of Immediate and Prolonged Release Tacrolimus Preparations

T. Elnahhas,^1,2 T. Lee,² M. Moreton,² D. McKeown,² J. Popoola,³ R. Ramkhelawon,³ A. Johnston,^1,2 I. MacPhee.³
Influence of POR*28 Genotype on Tacrolimus Disposition in Heart Transplant Recipients

T. Alford,¹ R. Page,¹ J. Lindenfeld,² C. Aquilante.¹
Influence of Race on P-Glycoprotein Function in Peripheral Blood Mononuclear Cells

K. Tornatore,¹ H. Minderman,² K. O'Loughlin,² K. Attwood,³ D. Brazeau,⁴ R. Venuto.⁵
Infusion of Human Factor 7a Restores Circulating Platelets and Prevents TMA in Pig-to-Baboon Liver Xenotransplantation

J. Shah, N. Navarro-Alvarez, H. Yeh, N. Elias, J. Ligocka, J. Markmann, M. Hertl, D. Sachs, P. Vagefi.
Inhibition of Endogenous Memory CD8 T Cell Infiltration Into Cardiac Allografts Subjected to Prolonged Cold Ischemic Storage Is Required to Promote Long-Term Graft Survival

N. Kohei,¹ H. Tsuda,^1,3 T. Tanaka,^1,4 S. Iida,² T. Abe,³ C. Su,¹ D. Kish,¹ K. Tanabe,² A. Valujskikh,¹ R. Fairchild.¹
Inhibition of mTOR Modulates SLPI Expression: A Potential Role in Kidney Transplant Patients

N. Ambrosi,¹ A. Dotta,² C. Pizarro,² D. Guerrieri,¹ A. Gonzalez,² C. Leiva,² L. Leon,² J. Mendiberri,³ M. Rial,² C. Incardona,⁴ E. Chuluyan,¹ D. Casadei.²
Inhibition of RhoA Pathway-Related Macrophage Functions Abrogates Chronic Rejection of Cardiac Allograft

M. Kloc, J. You, N. Tejpal, X. Li, R. Ghobrial.
Inhibition of T Cell Metabolism Reveals a New Approach to Preventing Graft Rejection

C.-F. Lee,^1,2 Y.-C. Lo,² G. Furtmüller,³ B. Oh,³ V. Andrade-Oliveira,² A. Thomas,⁴ G. Brandacher,³ J. Powell.²
Initial Experience With a Tailor-Made Simulation and Navigation Program Using a 3D Printer Model of Kidney Transplantation Surgery

M. Kusaka,¹ M. Sugimoto,² N. Fukami,¹ H. Sasaki,¹ M. Takenaka,¹ T. Ito,³ T. Kenmochi,³ R. Shiroki,¹ K. Hoshinaga.¹
Innate Immune Memory to Allogeneic Non-Self

H. Dai, A. Williams, M. Oberbarnscheidt, F. Lakkis.
Inside Out Autologous Neo-Liver Fabrication

P. Than, C. Davis, M. Findlay, W. Liu, T. Le, S. Khong, M. Melcher, G. Gurtner.
Integrated Clinical-Histological (ICH) Score System for the Evaluation of “Marginal” Donors in Kidney Transplantation

M. Fiorentino,¹ M. Rossini,¹ P. Gallo,¹ G. Castellano,¹ A. Schena,¹ G. Grandaliano,² P. Ditonno,³ M. Bataglia,³ L. Gesualdo.¹
Interactions Between Platelets and Liver Sinusoidal Endothelial Cells Initiate Liver Regeneration

J. Meyer,^1,2 E. Lejmi,² P. Fontana,^2,3 P. Morel,^1,2 C. Gonelle-Gispert,² L. Bühler.^1,2
Interference of Therapeutic Antibodies Used in Desensitization Protocols On Lymphocytotoxicity Crossmatch Results

D. Milongo,^1,3 G. Vieu,^2,4,3 S. Blavy,^2,4 A. Del Bello,^1,3 F. Sallusto,⁵ L. Rostaing,^1,3 N. Kamar,^1,3 N. Congy-Jolivet.^2,4,3
Interferon-Free Sofosvir/Ribavirin Treatment Achieves Excellent Sustained Viral Response in Post Liver Transplant HCV Recipients

M. Hamshow, K. Bortecen, R. Layman, A. Winnick, B. Gelb, G. Morgan, L. Teperman.
Interim Results of a Phase 1 Trial of Treg Adoptive Cell Transfer (TRACT) in Living Donor Kidney Transplant Recipients

J. Leventhal,¹ A. LeFever,² A. Skaro,¹ L. Gallon,¹ J. Mathew,¹ D. Stare,¹ I. Konieczna,¹ J. He,¹ G. Johnson.³
Interim Safety Experience in Transplant Patients Treated With Belatacept (Nulojix) in the Post-Approval Setting

T. Kou, J. Braga, S. Sibabrata, J. Preston, M. Harler, A. Gomez.
Interleukin-1 Receptor Signaling by Graft Stromal Cells Regulates Donor-Reactive CD8 T Cell Responses to Cardiac Allografts

S. Iida,¹ D. Kish,¹ R. Abe,² K. Tanabe,³ W. Baldwin,¹ R. Fairchild.¹
Interleukin-17 Deficiency Attenuates Renal Allograft Injury and Prolongs Survival in a Murine Transplantation Model

T. Kwan,^1,2 S. Chadban,^1,2 J. Ma,^1,2 S. Bao,^2,3 S. Alexander,^2,4 H. Wu.^1,2
Interleukin-17A Induced Human Mesenchymal Stem Cells Are Superior Modulators of Immunological Function

K. Sivanathan,^1,2,3 D. Rojas-Canales,^1,2 S. Grey,⁵ C. Hope,^1,2 R. Carroll,^1,4 S. Gronthos,^3,6 P. Coates.^1,2,3,4
Intermittent High Dose Intravenous Immunoglobulin as Treatment for Donor Specific Antibodies in Renal Transplant Recipients

P. Bolin,¹ K. Parker,² F. Rana,¹ W. Bryant,¹ P. Jawa,¹ R. Harland.³
Interrogation of Plasma Cell-Rich Acute Rejection in Human Kidney Allografts by Whole Transcriptome Sequencing

L. Mesnard, F. Campagne, H. Yang, D. Dadhania, J. Lee, S. Seshan, M. Suthanthiran, T. Muthukumar.
Interstitial Fibrosis Is the Critical Determinant of Impaired Renal Function in Transplant Glomerulopathy

D. Toki,¹ H. Ishida,¹ M. Okumi,¹ T. Shimizu,¹ H. Shirakawa,¹ M. Inui,¹ K. Omoto,¹ K. Unagami,¹ T. Kanzawa,¹ K. Honda,² J. Koike,³ K. Tanabe.¹
Interventional Treatment With Minimal Surgery Is an Effective Way for Acute Portal Vein Thrombosis After Pediatric Liver Transplantation: The Experience of Largest Pediatric Liver Transplantation Center in China

Y. Liu,¹ T. Lu,¹ C. Shen,¹ Q. Xia,¹ Y. Luo,¹ T. Zhou,¹ B. Qiu,¹ M. Zhang,¹ L. Han,¹ Q. Chen.²
Intimal Arteritis Associated With Subsequent Graft Dysfunction in ABO-Incompatible Kidney Transplantation

D. Toki,¹ H. Iahida,¹ M. Okumi,¹ T. Shimizu,¹ M. Inui,¹ K. Omoto,¹ H. Shirakawa,¹ K. Unagami,¹ K. Honda,² J. Koike,³ K. Tanabe.¹
Intra-Allograft Common Rejection Module (CRM) Expression in Kidney Transplants Diagnoses Acute Rejection and Predicts Long Term Graft Prognosis

Y. Ng, S. Roedder, O. Bestard, T. Sigdel, S.-C. Hsieh, M. Sarwal.
Intra-Lymphocyte Concentrations of Mycophenolic Acid Correlate With the Incidence of Early Graft Rejection in Renal Transplant Recipients

Z. Md Dom,² J. Coller,² R. Carroll,³ A. Somogyi,² B. Sallustio.¹
Intra-Renal Cytokine Measurement Detected During Kidney Allograft Biopsies Portend Severity of Histological Injury

N. Leca, S. Anderson, K. Muczynski.
Intraoperative Renal Replacement Therapy During Liver and Liver-Kidney Transplant: Outcomes of 155 Cases

M. Mai,¹ E. Golan,² K. Croome,¹ A. Keaveny,¹ B. Taner,¹ T. Gonwa,¹ H. Wadei.¹
Intrapatient Variability of Tacrolimus Blood Concentrations Following Renal Transplant – Acute Rejection or No Connection?

D. Katarey,^1,2 E. Ioannou,² I. MacPhee.^1,2
Intrapatient Variability of Tacrolimus Trough Levels and Outpatient Clinic Non-Attendance Rates Predict Poor Renal Allograft Survival

D. Goodall, M. Willicombe, A. McLean, D. Taube.
Invasive CMV-Infection of the Duodenal Cuff – An Underestimated Entity of CMV Infection and Its Potential Impact On Outcome After Pancreas Transplantation

A. Biglarnia,¹ B. von Zur-Mühlen,¹ S. Yamamoto,¹ D. Berglund,¹ M. Wagner,² A. Sedigh,¹ G. Tufveson,¹ E. Larsson,³ F. Sund.²
Inverse Monocytic Subset Profile in Blood and Tissue During Heart Transplant Rejection

T. van den Bosch,¹ M. Kraaij,¹ K. Caliskan,² A. Constantinescu,² O. Manintveld,² P. Leenen,³ C. Baan,¹ M. van Groningen,⁴ A. Rowshani.¹
Investigating Role of Early VTE Chemoprophylaxis in Kidney Transplant

D. Kendrick,¹ E. Kudlaty,¹ A. Kim,¹ P. Moorehead,¹ J. Augustine,² E. Sanchez,² V. Kashyap,¹ K. Woodside.²
Investigation of Myocardial Function in Pediatric Transplant Recipients

K. Sgambat, S. Clauss, M. Lasota, A. Moudgil.
Iron Deficiency Impairs Regulatory T Cell Induction

R. Danger,¹ E. Bonaccorsi-Riani,¹ E. Kodela,¹ H. Collins,² R. Hider,³ M. Martínez-Llordella,¹ A. Sánchez-Fueyo.¹
Is BK Viral Subtype Distribution of Donor And/Or Recipient Important for Subsequent BK Viral Infection After Living-Donor Transplantation?

A. Schwarz,¹ S. Linnenweber-Held,¹ H. Haller,¹ A. Heim,² C. Schmitt.²
Is BMI of 28 an Appropriate Cutoff for Simultaneous Pancreas Kidney Transplant in Type II Diabetes?

E. Ahmed, D. Bruce, I. Carmody, A. Cohen, G. Loss, T. Reichman, J. Seal, H. Bohorquez.
Is Electron Microscopy Adding a Diagnostic Advantage in the Evaluation of Renal Allograft Biopsies for Antibody Mediated Rejection (AMR)?

J. Papadimitriou, M. Chaudhry, C. Drachenberg, R. Ugarte, D. Klassen, E. Ramos, C. Cangro, B. Thomas, M. Mavanur, A. Haririan.
Is Ex Vivo Liver Perfusion a Safe Alternative to Cold Static Storage for the Preservation of Standard Criteria Grafts?

N. Goldaracena, V. Spetzler, M. Kaths, J. Echeverri, M. Selzner.
Is Organ Transplantation from Trypanosoma cruzi-Infected Donors Safe? An Autopsy-Based Study of Parasite Persistence in Chronic Chagasic Patients

L. Benvenuti, A. Roggério.
Is Pretransplant Anti-A/B Antibody Removal Prerequisite for Successful ABO Incompatible Kidney Transplantation in Children?

S. Shishido,¹ T. Kawamura,¹ Y. Hamasaki,² Y. Takahashi,¹ Y. Hyodo,¹ Y. Itabashi,¹ H. Nihei,¹ T. Yonekura,¹ Y. Inaba,² Y. Yoshida,² K. Sakai,¹ A. Aikawa.¹
Is the Pulsatile Kidney Preservation Machine a Vaulable Tool in Evaluating Kidney Suitability from Older Donors After Brain Death?

D. Paredes Zapata,¹ A. Ruiz Arranz,¹ C. Rodriguez Villar,¹ L. Peri Cussi,² A. Alcaraz Asensio,² R. Adalia Bartolome,¹ F. Oppenheimer Salinas.³
Is There a Difference in Patient and Graft Survival in Children Weighing <20 kg Versus Those Weighing >20 kg at the Time of Renal Transplantation?

P. Chandak,¹ J. Stojanovic,² R. Sivaprakasam,³ N. Mamode,¹ F. Calder,¹ J. Olsburgh,¹ M. Drage,¹ C. Callaghan,¹ J. Taylor,¹ G. Koffman,¹ J. Taylor,² S. Marks,⁴ N. Kessaris.¹
Is There a Protective Value for Low Level Donor Specific Antibodies to Prevent Cardiac Allograft Vasculopathy After Heart Transplant?

M. Kittleson, J. Patel, F. Liou, S. Siddiqui, J. Yabuno, D. Chang, D. Ramzy, L. Czer, F. Esmailian, N. Reinsmoen, J. Kobashigawa.
Is Transplant Volume Associated With Survival in Pediatric Liver Transplants?

W. Cherikh,¹ H. Kim,² A. Wilk,¹ C. Flavin,¹ E. Brewer.³
Ischemia Reperfusion Injury in Orthotopic Liver Transplantation Primes the Adaptive Immune Response and Generation of Proinflammatory Cytokines

A. Zarrinpar,¹ P. Rao,² C. Lassman,² V. Agopian,¹ F. Kaldas,¹ D. Farmer,¹ R. Busuttil,¹ Y. Zhai,¹ J. Kupiec-Weglinski,¹ E. Reed.²
Ischemia-Induced Endoplasmic Reticulum Stress Regulates Autophagy to Determine the Severity of Liver Ischemia Reperfusion Injury

H. Zhou,^1,2 J. Zhu,¹ S. Yue,¹ R. Busuttil,¹ J. Kupiec-Weglinski,¹ Y. Zhai.¹
Ischemic Cholangiopathy Following Liver Transplantation from Donation After Circulatory Death Donors: Role of Tissue Plasminogen Activator Flush

C. Kubal,¹ R. Mangus,¹ J. Fridell,¹ M. Wingler,² S. Nagai,¹ B. Ekser,¹ J. Tector.¹
Isolated Microcirculation Inflammation Negatively Impacts Renal Graft Function at 5 Years

A. Chapelet,¹ M. Touzot,¹ M. Fournier,² A. Cesbron,³ K. Renaudin,⁴ A. Moreau,⁴ E. Morelon,⁵ D. Anglicheau,⁶ M. Giral.¹
Isotype Switching of Antibodies to Vimentin Following Transplantation Is Associated With Development of Transplant Glomerulopathy Following Renal Transplantation

M. Gunasekaran,¹ T. Maw,³ R. Santos,³ J. Wellen,¹ S. Shenoy,¹ T. Mohanakumar.^1,2